SCHEMBL7541373

SCHEMBL7541373

NNC(=O)c1ccc2ccncc2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
MPO P05164 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
ADORA3 P0DMS8 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2A6 P11509 1/20 0.55
CYP2C19 P33261 1/20 0.55
SMYD3 Q9H7B4 2/20 0.53
NAMPT P43490 1/20 0.53
HDAC3 O15379 2/20 0.52
HDAC1 Q13547 2/20 0.52
HDAC2 Q92769 2/20 0.52
AKT1 P31749 4/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
LCK P06239 1/20 0.47
CSF1R P07333 1/20 0.47
KDR P35968 1/20 0.47
MAPK14 Q16539 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1519811 0.93 SMYD3 (0.60) KDM4EMPOCYP1A2CYP3A4ADORA3
SCHEMBL6027553 0.85 HDAC1 (0.51) KDM4ESMYD3NAMPTHDAC3HDAC1
SCHEMBL30824507 0.83 PLAU (0.53) KDM4ECYP3A4SMYD3NAMPTHDAC3
SCHEMBL9648378 0.82 MPO (0.56) KDM4EMPOCYP1A2CYP3A4ADORA3
SCHEMBL6648425 0.81 AR (0.55) KDM4ECYP3A4SMYD3NAMPTHDAC3
SCHEMBL29972759 0.81 AR (0.55) KDM4ECYP3A4SMYD3NAMPTHDAC3
SCHEMBL808434 0.80 MPO (0.58) KDM4EMPOCYP1A2CYP3A4ADORA3
SCHEMBL29488886 0.79 MRGPRX4 (0.56) KDM4ECYP3A4SMYD3NAMPTHDAC3
SCHEMBL1403704 0.79 MRGPRX4 (0.56) KDM4ECYP3A4SMYD3NAMPTHDAC3
SCHEMBL6648054 0.78 HDAC3 (0.80) SMYD3NAMPTHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116730995-B Hydrazide compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2024-06-25 CN disclosed
CN-116730995-A Hydrazide compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2023-09-12 CN disclosed
WO-2018039621-A1 INHIBITION OF OLIG2 ACTIVITY Curtana Pharmaceuticals, Inc. (US) 2018-03-01 WO disclosed
EP-0975600-A1 HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTITHROMBOTIC AGENTS Akzo Nobel N.V. (NL) 2000-02-02 EP disclosed
WO-1998047876-A1 HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTITHROMBOTIC AGENTS AKZO NOBEL N.V. (NL) 1998-10-29 WO disclosed